SUPER
WAITLIST
  1. Home
  2. Stocks
  3. BFBIO
  4. Announcements

BFBIO · PHARMACEUTICALS

BFBIO announcements BF Biosciences Limited

BF Biosciences Limited (BFBIO) has 61 notices stored from the exchange, from 23 Oct 2024 to 30 Oct 2026. The newest is dated 30 Oct 2026; the titles below are the exchange’s own words.

Every notice stored, newest first

DateKindTitle as filedPDF
30 Oct 2026Report sent to shareholdersTransmission of Quarterly Financial Statements for the Period Ended 30-09-2026PDF
28 Oct 2026General meetingCertified true copy of the resolutions passed in the Annual General Meeting of the CompanyPDF
28 Oct 2026Financial resultsFinancial Results for the Quarter Ended 30-09-2026PDF
28 Oct 2026Regulatory noticeAnnual Progress Report for the Year Ended June 30, 2026PDF
20 Oct 2026Board meetingBoard Meeting—
07 Oct 2026Report sent to shareholdersTransmission of Annual Financial Statements for the Year Ended 30-06-2026PDF
07 Oct 2026General meetingNotice of Annual General MeetingPDF
06 Oct 2026General meetingNotice of Annual General Meeting prior to publicationPDF
29 Sep 2026Financial resultsFinancial Results for the Year Ended 2026-06-30PDF
21 Sep 2026Board meetingBoard Meeting—
20 Aug 2026Material informationMaterial InformationPDF
14 Jul 2026Administrative noticeApproval of Annual Budget for FY 2026-27—
06 Jul 2026Board meetingBoard Meeting Other Than Financial Results—
09 Jun 2026Management changeAppointment of Director to Fill Casual VacancyPDF
02 Jun 2026Management changeIntimation of Passing Away of Mrs. Akhter Khalid Waheed, Director and Founding CEOPDF
01 Jun 2026Management changeAppointment of Director to Fill Casual VacancyPDF
30 Apr 2026Report sent to shareholdersTransmission of Quarterly Report for the Period Ended 31-03-2026PDF
28 Apr 2026Financial resultsFinancial Results for the Quarter Ended 31-03-2026PDF
20 Apr 2026Board meetingBoard Meeting—
17 Apr 2026Regulatory noticeHalf Yearly Progress Report - For the Period Ended 31 December 2025PDF
04 Mar 2026Management changeResignation of DirectorPDF
27 Feb 2026Report sent to shareholdersTransmission of Quarterly Financial Statements for the Period Ended 31-12-2025PDF
26 Feb 2026Financial resultsFinancial Results for the Quarter Ended 31-12-2025PDF
18 Feb 2026Board meetingBoard Meeting—
22 Dec 2025Board meetingDecisions of Emergent Board of Directors Meeting Held On Dec 19, 2025PDF
18 Dec 2025Board meetingEmergent Board Meeting Other Than Financial Results—
20 Nov 2025Corporate briefingCorporate Briefing Session - PresentationPDF
18 Nov 2025Corporate briefingCorporate Briefing SessionPDF
30 Oct 2025Report sent to shareholdersTransmission of Quarterly Financial Statements for the Period Ended 30-09-2025PDF
27 Oct 2025General meetingCertified true copy of the resolutions passed in the Annual General Meeting of the CompanyPDF
27 Oct 2025Financial resultsFinancial Results for the Quarter Ended 2025-09-30PDF
21 Oct 2025Regulatory noticeAnnual Progress Report for the Year Ended June 30, 2025PDF
17 Oct 2025Board meetingBoard Meeting—
14 Oct 2025Material informationMaterial InformationPDF
13 Oct 2025Shareholding disclosureDisclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations—
03 Oct 2025Report sent to shareholdersTransmission of Annual Financial Statements for the Year Ended 30-06-2025PDF
03 Oct 2025General meetingNotice of Annual General MeetingPDF
02 Oct 2025General meetingNotice of Annual General Meeting prior to publicationPDF
23 Sep 2025Financial resultsFinancial Results for the Year Ended 30-06-2025PDF
15 Sep 2025Board meetingBoard Meeting—
08 Jul 2025Board meetingEmergent Board Meeting Other Than Financial Results—
30 Apr 2025Report sent to shareholdersTransmission of Quarterly Report for the Period Ended 2025-03-31PDF
29 Apr 2025Financial resultsFinancial Results for the Quarter Ended 2025-03-31PDF
21 Apr 2025Board meetingBoard Meeting—
17 Apr 2025Shareholding disclosureDisclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations—
11 Apr 2025Regulatory noticeQuarterly Progress Report for the Period Ended December 31, 2024PDF
28 Feb 2025Report sent to shareholdersTransmission of Quarterly Report for the Period Ended 31-12-2024PDF
28 Feb 2025Financial resultsFinancial Results for the Quarter Ended 2024-12-31PDF
28 Feb 2025Financial resultsFinancial Results for the Quarter Ended 2024-12-31 REVOKED—
20 Feb 2025Board meetingBoard Meeting—
14 Jan 2025Material informationMaterial InformationPDF
24 Dec 2024Unusual price movement noticeClarification - Unusual Movement in Price of the Shares of the BF Biosciences LimitedPDF
26 Nov 2024Corporate briefingCorporate Briefing Session - PresentationPDF
22 Nov 2024Corporate briefingCorporate Briefing SessionPDF
14 Nov 2024AnnouncementMaterial InformaitonPDF
30 Oct 2024Report sent to shareholdersTransmission of Quarterly Report for the Period Ended 2024-09-30PDF
28 Oct 2024General meetingCertified true copy of the resolutions passed in the Annual General Meeting of the CompanyPDF
28 Oct 2024Financial resultsFinancial Results for the Quarter Ended 2024-09-30PDF
25 Oct 2024General meetingNotice of Annual General MeetingPDF
25 Oct 2024Report sent to shareholdersTransmission of Annual Report for the Year Ended 2024-06-30PDF
23 Oct 2024Board meetingBoard Meeting—

Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.

By kind

  • Board meeting: 13
  • Financial results: 10
  • Report sent to shareholders: 10
  • General meeting: 8
  • Corporate briefing: 4
  • Management change: 4
  • Regulatory notice: 4
  • Material information: 3
  • Shareholding disclosure: 2
  • Administrative notice: 1
  • Announcement: 1
  • Unusual price movement notice: 1

Counted from the 61 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.

More on BFBIO

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .